Is neopterin level a predictive and differential biomarker in patients with thyroid disorders?

Journal of Endocrinological Investigation

Volumn 32, Issue 2, 2009, Pages 147-149

  Sahin, T T ^a   Yuksel, O ^a   Girgin, G ^b   Sipahi, H ^b   Dikmen, K ^a   Azili, C ^a   Taneri, F ^a   Baydar, T ^b  

^a GAZI UNIVERSITY   (Turkey)

^b HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Biomarker; Neopterin; Thyroid cancer; Thyroid disorders

Indexed keywords

NEOPTERIN;

ADULT; ARTICLE; ASPIRATION BIOPSY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GOITER; HUMAN; MALE; THYROID CANCER; THYROID DISEASE; THYROIDITIS;

EID: 67649360187     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03345704     Document Type: Article

References (21)

1. Erdogan G, Erdogan ME, Emral M, et al. Iodine Status and prevalence in Turkey before mandatory iodization. J Endocrinol Invest 2002, 25: 224-8.
2. Hiroshimaya T, Takahashi H, Yao K, et al. Clinical review of thyroid malignant tumor. Acta Otolaryngol Suppl 2002, 547: 85-7.
3. Carcangiu ML, Zampi G, Pupi A, Castagnoli A, Rosai J. Papillary carcinoma of the thyroid. A clinicopathologic study of 241 cases treated at the University of Florence, Italy. Cancer 1985, 55: 805-28.
4. Ito Y, Hirokawa M, Jikuzono T, et al. Extranodal tumor extension to adjacent organs predicts a worse cause-specific survival in patients with papillary thyroid carcinoma. World J Surg 2007,31: 1194-201.
5. Reibnegger G, Weiss G, Wachter H. Neopterin in malignant diseases. Tumour Marker Update 1992, 4: 101-3.
6. Altindag ZZ, Sahin G, Kansu E, Duru S. Urinary neopterin levels in patient with leukemia. NewJ Med Suppl 1995, 12: 29-32.
7. Yuksel O, Sahin TT, Girgin G, et al. Neopterin, catalase and superoxide dismutase in females with benign and malignant breast tumors. Pteridines 2007, 18: 132-8.
8. Murr C, Bergant A, Widschwendter M, Heim K, Schröcksnadel H, Fuchs D. Neopterin is an independent prognostic variable in females with breast cancer. Clin Chem 1999, 45: 1998-2004.
9. Murr C, Widner B, Wirleitner B, Fuchs D. Neopterin as a marker for immune system activation. Curr Drug Metab 2002,3: 175-87.
10. Berdowska A, Zwirska-Korczala K. Neopterin measurement in clinical diagnosis. J Clin Pharm Therap 2001,26: 319-29.
11. Fukuda A, Mazda T, Gyure WL, at al. A comparative study of urinary xanthopterin and neopterin in liver diseases. Eur J Clin Chem Clin Biochem 1993, 31: 129-34.
12. Altindag ZZ, Baydar T, Isimer A, Sahin G. Neopterin as a new biomarker for the evaluation of occupational exposure to silica. mt Arch Occup Environ Health 2003, 76: 318-22.
13. Baydar T, Engln AB, Aydin A, Sahin G. Effect of aluminum exposure on pteridine metabolism. Biol Trace Elem Res 2005, 106: 153-64.
14. Bjelakovic G, Jevtovic-Stoimenov T, Bjelakovic B, Stojanovic I. Biochemical functions and clinical importance of unconjugated pteridines. Facta Universitatis Med Biol 2004, 11: 49-52.
15. Huber C, Batchelor JR, Fuchs D, et al. Immune response-associated production of neopterin-Release from macrophages primarily under control of interferon-gamma. J Exp Med 1984, 160: 310-6.
16. Reibnegger G, Fuchs D, Fuith LC, et al. Neopterin as a marker for activated cell-mediated immunity: application in malignant disease. Cancer Detect Prey 1991, 15: 483-90.
17. Fuchs D, Weiss G, Reibnegger G, Wachter H. The role of neopterin as a monitor of cellular activation in transplantation, inflammatory, infectious and malignant disease. Crit Rev Clin Chem 1992, 29: 307-41.
18. Kawasaki H, Watanabe H, Yamada S, Watanabe K, Suyama A. Prognostic significance of urinary neopterin levels in patients with hepatocellular carcinoma. Tohoku J Exp Med 1988, 155: 311-8.
19. Hoffmann G, Wirleitner B, Fuchs D. Potential role of immune system activation associated production of neopterin derivatives in humans. lnflamm Res 2003, 52: 313-21.
20. Wagner R, Hayatghebi S, Rosenkranz M, Reinwein D. Increased serum neopterin levels in patients with Graves' disease. Exp Clin Endocrinol 1993, 101: 249-54.
21. Schomburg A, Grünwald F, Schultes B, Hote A, Bender H, Biersack HJ. Are serum neopterin concentrations superior to other parameters in the differential diagnosis and prognostic assessment of Graves' disease? Exp Clin Endocrinol Diabetes 1996, 104: 123-9.